183 related articles for article (PubMed ID: 32362501)
1. Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu.
Zhang D; Kinloch AJ; Srinath A; Shenkar R; Girard R; Lightle R; Moore T; Koskimäki J; Mohsin A; Carrión-Penagos J; Romanos S; Shen L; Clark MR; Shi C; Awad IA
J Autoimmun; 2020 Sep; 113():102469. PubMed ID: 32362501
[TBL] [Abstract][Full Text] [Related]
2. B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models.
Shi C; Shenkar R; Zeineddine HA; Girard R; Fam MD; Austin C; Moore T; Lightle R; Zhang L; Wu M; Cao Y; Gunel M; Louvi A; Rorrer A; Gallione C; Marchuk DA; Awad IA
J Neuroimmune Pharmacol; 2016 Jun; 11(2):369-77. PubMed ID: 27086141
[TBL] [Abstract][Full Text] [Related]
3. Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations.
Shi C; Shenkar R; Kinloch A; Henderson SG; Shaaya M; Chong AS; Clark MR; Awad IA
J Neuroimmunol; 2014 Jul; 272(1-2):67-75. PubMed ID: 24864012
[TBL] [Abstract][Full Text] [Related]
4. Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis.
Kinloch AJ; Chang A; Ko K; Henry Dunand CJ; Henderson S; Maienschein-Cline M; Kaverina N; Rovin BH; Salgado Ferrer M; Wolfgeher D; Liarski V; Haddon DJ; Utz PJ; Wilson PC; Clark MR
Arthritis Rheumatol; 2014 Dec; 66(12):3359-70. PubMed ID: 25306868
[TBL] [Abstract][Full Text] [Related]
5. Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation.
Shi C; Shenkar R; Batjer HH; Check IJ; Awad IA
J Neurosurg; 2007 Nov; 107(5):1023-6. PubMed ID: 17977276
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells.
Detter MR; Snellings DA; Marchuk DA
Circ Res; 2018 Oct; 123(10):1143-1151. PubMed ID: 30359189
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.
Zhu Y; Wu Q; Fass M; Xu JF; You C; Müller O; Sandalcioglu IE; Zhang JM; Sure U
Neurosurgery; 2011 Sep; 69(3):722-31; discussion 731-2. PubMed ID: 21471841
[TBL] [Abstract][Full Text] [Related]
8. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
9. Novel Murine Models of Cerebral Cavernous Malformations.
Detter MR; Shenkar R; Benavides CR; Neilson CA; Moore T; Lightle R; Hobson N; Shen L; Cao Y; Girard R; Zhang D; Griffin E; Gallione CJ; Awad IA; Marchuk DA
Angiogenesis; 2020 Nov; 23(4):651-666. PubMed ID: 32710309
[TBL] [Abstract][Full Text] [Related]
10. Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition.
Bravi L; Malinverno M; Pisati F; Rudini N; Cuttano R; Pallini R; Martini M; Larocca LM; Locatelli M; Levi V; Bertani GA; Dejana E; Lampugnani MG
Stroke; 2016 Mar; 47(3):886-90. PubMed ID: 26839352
[TBL] [Abstract][Full Text] [Related]
11. Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
McDonald DA; Shi C; Shenkar R; Gallione CJ; Akers AL; Li S; De Castro N; Berg MJ; Corcoran DL; Awad IA; Marchuk DA
Hum Mol Genet; 2014 Aug; 23(16):4357-70. PubMed ID: 24698976
[TBL] [Abstract][Full Text] [Related]
12. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways.
Li J; Zhao Y; Coleman P; Chen J; Ting KK; Choi JP; Zheng X; Vadas MA; Gamble JR
Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165519. PubMed ID: 31369819
[TBL] [Abstract][Full Text] [Related]
13. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome analysis provides new molecular signatures in sporadic Cerebral Cavernous Malformation endothelial cells.
Scimone C; Donato L; Alibrandi S; Esposito T; Alafaci C; D'Angelo R; Sidoti A
Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165956. PubMed ID: 32877751
[TBL] [Abstract][Full Text] [Related]
15. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation.
Weng J; Yang Y; Song D; Huo R; Li H; Chen Y; Nam Y; Zhou Q; Jiao Y; Fu W; Yan Z; Wang J; Xu H; Di L; Li J; Wang S; Zhao J; Wang J; Cao Y
Am J Hum Genet; 2021 May; 108(5):942-950. PubMed ID: 33891857
[TBL] [Abstract][Full Text] [Related]
16. Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology.
Jauhiainen S; Onyeogaziri FC; Lazzaroni F; Conze LL; Laakkonen JP; Laham-Karam N; Laakso A; Niemelä M; Rezai Jahromi B; Magnusson PU
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167139. PubMed ID: 38537685
[TBL] [Abstract][Full Text] [Related]
17. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Zhou Z; Tang AT; Wong WY; Bamezai S; Goddard LM; Shenkar R; Zhou S; Yang J; Wright AC; Foley M; Arthur JS; Whitehead KJ; Awad IA; Li DY; Zheng X; Kahn ML
Nature; 2016 Apr; 532(7597):122-6. PubMed ID: 27027284
[TBL] [Abstract][Full Text] [Related]
18. YKL-40 can promote angiogenesis in sporadic cerebral cavernous malformation (CCM).
Shi Y; Song Y; Liu P; Li P
J Clin Neurosci; 2019 Jun; 64():220-226. PubMed ID: 30948312
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.
Tan H; Liu T; Wu Y; Thacker J; Shenkar R; Mikati AG; Shi C; Dykstra C; Wang Y; Prasad PV; Edelman RR; Awad IA
Invest Radiol; 2014 Jul; 49(7):498-504. PubMed ID: 24619210
[TBL] [Abstract][Full Text] [Related]
20. Vascular smooth muscle cell differentiation in human cerebral vascular malformations.
Uranishi R; Baev NI; Kim JH; Awad IA
Neurosurgery; 2001 Sep; 49(3):671-9; discussion 679-80. PubMed ID: 11523679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
